FeesSafety
Pluang+

LifeVantage to report Q1 FY2027 results on Nov 9 with a live investor call.

Company Fundamentals
26 Oct 2026, 23:05 WIB
GlobeNewsWire
View Source
Neutral
LifeVantage to report Q1 FY2027 results on Nov 9 with a live investor call.

LifeVantage Corporation announced it will release its financial results for the first quarter of fiscal year 2027, ending September 30, 2026, after market close on November 9, 2026. The company will host a conference call for investors the same day to discuss the results. LifeVantage is a health and wellness company specializing in nutrigenomics-based products that support cellular health. Investors can join the call via phone or webcast, with a replay available until November 30, 2026.

LifeVantage's upcoming fiscal Q1 2027 results announcement is noted here with Pluang's health sector market data for context. For readers following health stocks, as of Oct 27, 2026 03:11 WIB, out of 150 priced US health-sector stocks on Pluang, 80 rose and 70 fell. Key movers include TNGX at USD 22.09 with a 1-day change of -5.36% and Pluang order activity of 14% Sell / 86% Buy, BNGO at USD 1.12 down 5.08% with 100% Sell orders, and IBRX at USD 7.83 down 4.74% with a typical hold time of 4 days.

More News

Exodus Movement to announce Q3 2026 financial results on Nov 9 with a webcast.

Exodus Movement to announce Q3 2026 financial results on Nov 9 with a webcast.

Exodus Movement, a self-custodial finance and payments platform, will release its third quarter 2026 financial results after market close on November 9, 2026. The company will host a webcast at 5:00 PM ET the same day to discuss the results. Founded ...

Company Fundamentals
Neutral
1 hour ago
Onco360 named national pharmacy partner for AstraZeneca's lung cancer drug Zegfrovy.

Onco360 named national pharmacy partner for AstraZeneca's lung cancer drug Zegfrovy.

Onco360, a leading independent specialty pharmacy, has been selected by AstraZeneca as a national pharmacy partner for Zegfrovy (sunvozertinib), a treatment for advanced non-small cell lung cancer with EGFR exon 20 insertion mutations. Zegfrovy has s...

Market News
Bullish
1 hour ago
S4A IT Solutions joins SAP PartnerEdge program, boosting its SAP consulting capabilities.

S4A IT Solutions joins SAP PartnerEdge program, boosting its SAP consulting capabilities.

S4A IT Solutions has been accepted into the SAP PartnerEdge program, marking a key milestone in its growth. This partnership enhances S4A's ability to help organizations maximize their SAP investments, especially in areas like asset management and su...

Market News
Bullish
2 hours ago
SEC policy shifts and rising shareholder activism shape 2027 proxy season preparations for public companies

SEC policy shifts and rising shareholder activism shape 2027 proxy season preparations for public companies

Public companies are facing new challenges for the 2027 proxy season due to changes in SEC policies, evolving shareholder activism strategies, and shifts in institutional investor voting. A virtual roundtable on October 28 will gather experts to disc...

Market News
Neutral
3 hours ago
Gogo to release Q3 2026 earnings on Nov 6 with a conference call for analysts.

Gogo to release Q3 2026 earnings on Nov 6 with a conference call for analysts.

Gogo Inc., a leading provider of in-flight broadband connectivity, announced it will report its third quarter 2026 financial results on November 6, 2026, before the market opens. The company will hold a conference call with financial analysts the sam...

Company Fundamentals
Neutral
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App